These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17941958)

  • 1. Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis.
    Duncan FJ; Wulff BC; Tober KL; Ferketich AK; Martin J; Thomas-Ahner JM; Allen SD; Kusewitt DF; Oberyszyn TM; Vanbuskirk AM
    Am J Transplant; 2007 Dec; 7(12):2693-703. PubMed ID: 17941958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with co-administration of cyclosporine A.
    Wulff BC; Kusewitt DF; VanBuskirk AM; Thomas-Ahner JM; Duncan FJ; Oberyszyn TM
    J Invest Dermatol; 2008 Oct; 128(10):2467-73. PubMed ID: 18463679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and late effects of the immunosuppressants rapamycin and mycophenolate mofetil on UV carcinogenesis.
    de Gruijl FR; Koehl GE; Voskamp P; Strik A; Rebel HG; Gaumann A; de Fijter JW; Tensen CP; Bavinck JN; Geissler EK
    Int J Cancer; 2010 Aug; 127(4):796-804. PubMed ID: 19998342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF.
    Gallon L; Perico N; Dimitrov BD; Winoto J; Remuzzi G; Leventhal J; Gaspari F; Kaufman D
    Am J Transplant; 2006 Jul; 6(7):1617-23. PubMed ID: 16827862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proliferation effects of sirolimus, cyclosporine A and mycophenolate mofetil on human transitional cell carcinoma cells].
    Lin J; Wang YH; Zhang YH; Tian Y
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(6):388-91. PubMed ID: 22490898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary immunosuppressants do not enhance UV-induced skin carcinogenesis, and reveal discordance between p53-mutant early clones and carcinomas.
    Voskamp P; Bodmann CA; Koehl GE; Rebel HG; Van Olderen MG; Gaumann A; El Ghalbzouri A; Tensen CP; Bavinck JN; Willemze R; Geissler EK; De Gruijl FR
    Cancer Prev Res (Phila); 2013 Feb; 6(2):129-38. PubMed ID: 23233735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination.
    Fortin MC; Raymond MA; Madore F; Fugère JA; Pâquet M; St-Louis G; Hébert MJ
    Am J Transplant; 2004 Jun; 4(6):946-52. PubMed ID: 15147429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus/mycophenolate mofetil) after heart transplantation: 5-year results.
    Kaczmarek I; Zaruba MM; Beiras-Fernandez A; Reimann R; Nickel T; Grinninger C; Sadoni S; Hagl C; Meiser B
    J Heart Lung Transplant; 2013 Mar; 32(3):277-84. PubMed ID: 23415313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients.
    Silva HT; Yang HC; Abouljoud M; Kuo PC; Wisemandle K; Bhattacharya P; Dhadda S; Holman J; Fitzsimmons W; First MR
    Am J Transplant; 2007 Mar; 7(3):595-608. PubMed ID: 17217442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study.
    Claes K; Meier-Kriesche HU; Schold JD; Vanrenterghem Y; Halloran PF; Ekberg H
    Nephrol Dial Transplant; 2012 Feb; 27(2):850-7. PubMed ID: 21617197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low-dose corticosteroids in primary kidney transplantation: 18-year results.
    Ciancio G; Gaynor JJ; Guerra G; Roth D; Chen L; Kupin W; Mattiazzi A; Ortigosa-Goggins M; Moni L; Burke GW
    Clin Transplant; 2020 Dec; 34(12):e14123. PubMed ID: 33070366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT; Ottosen P; Starklint H; Dieperink H
    Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
    Guethoff S; Meiser BM; Groetzner J; Eifert S; Grinninger C; Ueberfuhr P; Reichart B; Hagl C; Kaczmarek I
    Transplantation; 2013 Feb; 95(4):629-34. PubMed ID: 23423270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
    Tsai MK; Wu FL; Lai IR; Lee CY; Hu RH; Lee PH
    Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib reduces the effects of acute and chronic UVB exposure in mice treated with therapeutically relevant immunosuppressive drugs.
    Wulff BC; Thomas-Ahner JM; Schick JS; Oberyszyn TM
    Int J Cancer; 2010 Jan; 126(1):11-8. PubMed ID: 19609953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal aberrations in UVB-induced tumors of immunosuppressed mice.
    Dworkin AM; Tober KL; Duncan FJ; Yu L; VanBuskirk AM; Oberyszyn TM; Toland AE
    Genes Chromosomes Cancer; 2009 Jun; 48(6):490-501. PubMed ID: 19296524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy.
    Anil Kumar MS; Heifets M; Fyfe B; Saaed MI; Moritz MJ; Parikh MH; Kumar A
    Transplantation; 2005 Sep; 80(6):807-14. PubMed ID: 16210969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azathioprine, UV light, and skin cancer in organ transplant patients--do we have an answer?
    Ulrich C; Stockfleth E
    Nephrol Dial Transplant; 2007 Apr; 22(4):1027-9. PubMed ID: 17234668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.